Pirfenidone | Interleukin Related interleukin-related.com

Product Name :
Pirfenidone

Search keywords :
Pirfenidone

drugId :
null

Target Vo:
Transforming growth factor beta

Target Vo Short Name :
TGF-β

Moa_Name:
Transforming growth factor beta inhibitors

First Approval Country :
Japan

First Approval Date Filter:
2008

Origin Company_Name :
Intermune Inc

Active Company_Name :
Beijing Continent Pharmaceutical Co Ltd

Active Indication_Name:
Idiopathic Pulmonary Fibrosis

In Active Indication_Name:
Hermanski-Pudlak Syndrome

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bermekimab manufacturer
Peresolimab In Vitro
TRITC-conjugated AffiniPure Goat Anti-Mouse IgG H&L: TRITC-conjugated AffiniPure Goat Anti-Mouse IgG H&Lis an -conjugated, goat-derived anti-mouse IgG antibody. TRITC-conjugated AffiniPure Goat Anti-Mouse IgG H&L conjugates the light and heavy chains of mouse IgG antibodies for use in ICC/IF, FC experiments in the mouse context.

Author: Interleukin Related

Related Posts